Back to Browse Journals » Journal of Healthcare Leadership » Volume 5

Global health care leadership development: trends to consider

Authors MacPhee M, Chang L, Lee D, Spiri W

Received 9 March 2013

Accepted for publication 12 April 2013

Published 10 June 2013 Volume 2013:5 Pages 21—29

DOI http://dx.doi.org/10.2147/JHL.S23010

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Maura MacPhee,1 Lilu Chang,2 Diana Lee,3 Wilza Spiri4

1University of British Columbia School of Nursing, Vancouver, British Columbia, Canada; 2Center for Advancement of Nursing Education, Koo Foundation, Sun Yat-Sen Cancer Center, Taipei, Taiwan; 3Nethersole School of Nursing, Chinese University of Hong Kong, Hong Kong, 4São Paulo State University, Botucatu, São Paulo, Brazil

Abstract: This paper provides an overview of trends associated with global health care leadership development. Accompanying these trends are propositions based on current available evidence. These testable propositions should be considered when designing, implementing, and evaluating global health care leadership development models and programs. One particular leadership development model, a multilevel identity model, is presented as a potential model to use for leadership development. Other, complementary approaches, such as positive psychology and empowerment strategies, are discussed in relation to leadership identity formation. Specific issues related to global leadership are reviewed, including cultural intelligence and global mindset. An example is given of a nurse leadership development model that has been empirically tested in Canada. Through formal practice–academic–community collaborations, this model has been locally adapted and is being used for nurse leader training in Hong Kong, Taiwan, and Brazil. Collaborative work is under way to adapt the model for interprofessional health care leadership development.

Keywords: health care leadership, development models, global trends, collective

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

The multinational second Diabetes, Attitudes, Wishes and Needs study: results of the French survey

Reach G, Consoli SM, Halimi S, Colas C, Duclos M, Fontaine P, Martineau C, Avril C, Tourette-Turgis C, Pucheu S, Brunet O

Patient Preference and Adherence 2015, 9:289-297

Published Date: 12 February 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Managing hemophilia: the role of mobile technology

Khair K, Holland M

Smart Homecare Technology and TeleHealth 2014, 2:39-44

Published Date: 6 May 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

The use of telephone monitoring for diabetic patients: theory and practical implications

Koutsouris D, Lazakidou A, Vellidou E, Iliopoulou D, Petridou M, Koutsouri G, Giokas K, Fotiadis D

Smart Homecare Technology and TeleHealth 2014, 2:13-17

Published Date: 17 March 2014

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]

Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M

Biologics: Targets and Therapy 2013, 7:265-266

Published Date: 6 December 2013